DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Mylan Inc. (NASDAQ: MYL)



company name or ticker
Company Photos
(Click to zoom)

PRGO, GSK And MYL, 3 Drugs Stocks Pushing The Industry Lower

Actavis Beats on Q3 Earnings, Guides Above Expectations - Analyst Blog

Mylan Is Near All-Time High Levels But Still A Strong Buy

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog

Mylan Beats, Raises Earnings Guidance; Abbott Deal on Track - Analyst Blog

Mylan (MYL) Earnings Report: Q3 2014 Conference Call Transcript

Mylan (MYL) Highlighted As Momo Momentum Stock

Pfizer's Trumenba Gains Accelerated Approval in the U.S. - Analyst Blog

Is Mylan's Lively Third Quarter the Start of Something Special?

Mylan posts Street-beating top and bottom lines behind strong growth in Q3 -- and successfully completing its agreement to purchase a portion of Abbott Labs' generics business could lead to more success ahead.

Mylan's (MYL) CEO Heather Bresch on Q3 2014 Results - Earnings Call Transcript

See More Articles...